KERYX BIOPHARMACEUTICALS INC Interest Expense
KERYX BIOPHARMACEUTICALS INC reported Interest Expense of $144.00 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2018-11-08
- KERYX BIOPHARMACEUTICALS INC interest expense for the quarter ending 2018-09-30 was $144.00K.
- KERYX BIOPHARMACEUTICALS INC interest expense for the quarter ending 2017-12-31 was $63.00M.
- KERYX BIOPHARMACEUTICALS INC interest expense for the quarter ending 2017-09-30 was $0.00.
- KERYX BIOPHARMACEUTICALS INC interest expense for the quarter ending 2017-06-30 was $63.00M, a 240.54% increase year-over-year.
- KERYX BIOPHARMACEUTICALS INC interest expense for fiscal 2017 was $63.00M, a 84.21% increase from fiscal 2016.
- KERYX BIOPHARMACEUTICALS INC interest expense for fiscal 2016 was $34.20M, a 201.14% increase from fiscal 2015.
- KERYX BIOPHARMACEUTICALS INC interest expense for fiscal 2015 was $11.36M.
- KERYX BIOPHARMACEUTICALS INC interest expense for fiscal 2014 was $0.00.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2018-09-30 | $144.00K 10-Q · filed 2018-11-08 | $144.00K 10-Q · filed 2018-11-08 | ||||
| 2017-12-31 | $63.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $63.00M derived: sum of 2 quarters · filed 2018-11-08 | $126.00M derived: sum of 3 quarters · filed 2018-11-08 | $63.00M 10-K · filed 2018-02-21 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-08 | $63.00M derived: sum of 2 quarters · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | $63.00M 10-Q · filed 2017-11-07 | $63.00M derived: sum of 4 quarters · filed 2018-11-08 | |
| 2017-06-30 | $63.00M 10-Q · filed 2017-07-27 | $63.00M 10-Q · filed 2017-07-27 | $63.00M derived: sum of 3 quarters · filed 2018-02-21 | $63.00M derived: sum of 4 quarters · filed 2018-02-21 | ||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-04 | $0.00 derived: sum of 2 quarters · filed 2018-02-21 | $0.00 derived: sum of 3 quarters · filed 2018-02-21 | $18.50M derived: sum of 4 quarters · filed 2018-02-21 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $0.00 derived: sum of 2 quarters · filed 2018-02-21 | $18.50M derived: sum of 3 quarters · filed 2018-02-21 | $34.20M 10-K · filed 2018-02-21 | $34.21M 10-K · filed 2017-03-01 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-09 | $18.50M derived: sum of 2 quarters · filed 2016-11-09 | $34.20M 10-Q · filed 2016-11-09 | |||
| 2016-06-30 | $18.50M 10-Q · filed 2016-08-05 | $34.20M 10-Q · filed 2016-08-05 | ||||
| 2016-03-31 | $15.70M 10-Q · filed 2016-04-28 | |||||
| 2015-12-31 | $11.36M 10-K · filed 2017-03-01 | |||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-01 |